Operating Margin of Immunome Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Immunome Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Immunome Inc. Operating Margin for the quarter ending 30 Sep 2025 was -2420%, a 23% increase year-over-year.
  • Immunome Inc. annual Operating Margin for 2024 was -3382%, a 333% decline from 2023.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Immunome Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -2420% +715% +23% 01 Jul 2025 30 Sep 2025
Q2 2025 -1784% +734% +29% 01 Apr 2025 30 Jun 2025
Q1 2025 -1994% -123% -6.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -3382% -2601% -333% 01 Oct 2024 31 Dec 2024
Q3 2024 -3134% 01 Jul 2024 30 Sep 2024
Q2 2024 -2518% 01 Apr 2024 30 Jun 2024
Q1 2024 -1871% 01 Jan 2024 31 Mar 2024
Q4 2023 -781% 01 Oct 2023 31 Dec 2023

Immunome Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -3382% -2601% -333% 01 Jan 2024 31 Dec 2024
2023 -781% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.